These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12559610)

  • 1. Intra-individual variations of fasting plasma lipids, apolipoproteins and postprandial lipemia in familial combined hyperlipidemia compared to controls.
    Delawi D; Meijssen S; Castro Cabezas M
    Clin Chim Acta; 2003 Feb; 328(1-2):139-45. PubMed ID: 12559610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia.
    Verseyden C; Meijssen S; van Dijk H; Jansen H; Castro Cabezas M
    J Lipid Res; 2003 Nov; 44(11):2100-8. PubMed ID: 12923226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of atorvastatin on fasting plasma and marginated apolipoproteins B48 and B100 in large, triglyceride-rich lipoproteins in familial combined hyperlipidemia.
    Verseyden C; Meijssen S; Cabezas MC
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5021-9. PubMed ID: 15472200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in postprandial ketone bodies in normolipidemic subjects and in untreated patients with familial combined hyperlipidemia.
    Halkes CJ; van Dijk H; Verseyden C; de Jaegere PP; Plokker HW; Meijssen S; Erkelens DW; Cabezas MC
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1875-80. PubMed ID: 12933534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations.
    Couillard C; Bergeron N; Bergeron J; Pascot A; Mauriège P; Tremblay A; Prud'homme D; Bouchard C; Després JP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4575-82. PubMed ID: 11134111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of atorvastatin on the clearance of triglyceride-rich lipoproteins in familial combined hyperlipidemia.
    Castro Cabezas M; Verseyden C; Meijssen S; Jansen H; Erkelens DW
    J Clin Endocrinol Metab; 2004 Dec; 89(12):5972-80. PubMed ID: 15579746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia.
    Meijssen S; van Dijk H; Verseyden C; Erkelens DW; Cabezas MC
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):811-6. PubMed ID: 12006395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutrition, body weight and deterioration of familial combined hyperlipidemia.
    Koprovicová J; Kollár J; Petrásová D
    Coll Antropol; 2006 Dec; 30(4):777-82. PubMed ID: 17243549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia.
    Verseyden C; Meijssen S; Castro Cabezas M
    J Lipid Res; 2002 Feb; 43(2):274-80. PubMed ID: 11861669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with postprandial lipemia and apolipoprotein A-V levels in individuals with familial combined hyperlipidemia.
    Almeda-Valdes P; Cuevas-Ramos D; Mehta R; Muñoz-Hernandez L; Cruz-Bautista I; Perez-Mendez O; Tusie-Luna MT; Gomez-Perez FJ; Pajukanta P; Matikainen N; Taskinen MR; Aguilar-Salinas CA
    BMC Endocr Disord; 2014 Nov; 14():90. PubMed ID: 25425215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diurnal triglyceride profiles: a novel approach to study triglyceride changes.
    Castro Cabezas M; Halkes CJ; Meijssen S; van Oostrom AJ; Erkelens DW
    Atherosclerosis; 2001 Mar; 155(1):219-28. PubMed ID: 11223445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low plasma vitamin A concentrations in familial combined hyperlipidemia.
    Ribalta J; LaVille AE; Girona J; Vallvé JC; Masana L
    Clin Chem; 1997 Dec; 43(12):2379-83. PubMed ID: 9439457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemia.
    Meijssen S; Cabezas MC; Twickler TB; Jansen H; Erkelens DW
    J Lipid Res; 2000 Jul; 41(7):1096-102. PubMed ID: 10884291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects.
    Vergès B; Guerci B; Durlach V; Galland-Jos C; Paul JL; Lagrost L; Gambert P
    J Lipid Res; 2001 Dec; 42(12):2021-9. PubMed ID: 11734575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of age and relative weight on the presentation of familial combined hyperlipidemia in childhood.
    Shamir R; Tershakovec AM; Gallagher PR; Liacouras CA; Hayman LL; Cortner JA
    Atherosclerosis; 1996 Mar; 121(1):85-91. PubMed ID: 8678927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diurnal triglyceridaemia and insulin resistance in mildly obese subjects with normal fasting plasma lipids.
    Halkes CJ; Van Wijk JP; Ribalta J; Masana L; Castro Cabezas M
    J Intern Med; 2004 Jan; 255(1):74-81. PubMed ID: 14687241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis.
    van Wijk JP; Buirma R; van Tol A; Halkes CJ; De Jaegere PP; Plokker HW; van der Helm YJ; Castro Cabezas M
    Atherosclerosis; 2005 Jan; 178(1):147-55. PubMed ID: 15585212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between postprandial lipemia and atherogenic factors in healthy subjects by considering gender differences.
    Orem A; Yaman SO; Altinkaynak B; Kural BV; Yucesan FB; Altinkaynak Y; Orem C
    Clin Chim Acta; 2018 May; 480():34-40. PubMed ID: 29408168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia.
    Cruz-Bautista I; Mehta R; Cabiedes J; García-Ulloa C; Guillen-Pineda LE; Almeda-Valdés P; Cuevas-Ramos D; Aguilar-Salinas CA
    Clin Chim Acta; 2015 Jan; 438():160-5. PubMed ID: 25172037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.